Ebglyss Dosage & Drug Information

Information is sourced from publicly available references. The information is for educational purpose of healthcare professionals and we are not liable for any loss or damage.

Core Prescribing Info

Contents

Lebrikizumab

Indications/Uses

Moderate-to-severe atopic dermatitis in adults & adolescents ≥12 yr w/ body wt at least 40 kg who are candidates for systemic therapy.

Dosage/Direction for Use

SC 500 mg (two 250 mg inj) at both wk 0 & 2, followed by 250 mg every other wk up to wk 16. Maintenance dose: 250 mg every 4th wk once clinical response is achieved.

Contraindications

Hypersensitivity.

MIMS Class

Other Dermatologicals

ATC Classification

D11AH10 - lebrikizumab ; Belongs to the class of agents for atopic dermatitis, excluding corticosteroids. Used in the treatment of atopic dermatitis.

Regulatory Classification

POM

Presentation/Packing

Form

Ebglyss soln for inj 250 mg/2 mL

Packing/Price

1's

Ebglyss

Manufacturer:

Eli Lilly and Company